AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Neuphoria Therapeutics Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01RFZ8667
3.44▼ 0.04 (-1.15%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.48
Day's Range
3.37 – 3.59
52-Week Range
3.19 – 8.44
Volume
73.0K
Avg Volume
19.0K
Share Statistics
Shares Outstanding
Employees
8
Exchange
XNAS
Listed
2021-12-16
Share count as of September 17, 2026

Neuphoria Therapeutics Inc. Common Stock (NEUP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Neuphoria Therapeutics Inc. Common Stock (NEUP)
What is Neuphoria Therapeutics Inc. Common Stock's Market Cap?
Neuphoria Therapeutics Inc. Common Stock's Market Cap is $18.6M, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's Enterprise Value?
Neuphoria Therapeutics Inc. Common Stock's Enterprise Value is -$1.3M, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's Price / Sales?
Neuphoria Therapeutics Inc. Common Stock's Price / Sales is 15.9×, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's EV / Revenue?
Neuphoria Therapeutics Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's EV / EBITDA?
Neuphoria Therapeutics Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's Revenue (TTM)?
Neuphoria Therapeutics Inc. Common Stock's Revenue (TTM) is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's Net Income (TTM)?
Neuphoria Therapeutics Inc. Common Stock's Net Income (TTM) is -$13.5M, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's EBITDA?
Neuphoria Therapeutics Inc. Common Stock's EBITDA is -$15.8M, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's Diluted EPS (TTM)?
Neuphoria Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -2.49, based on as-reported figures from SEC (XBRL) filings.
What is Neuphoria Therapeutics Inc. Common Stock's EBITDA Margin?
Neuphoria Therapeutics Inc. Common Stock's EBITDA Margin is -1344.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NEUPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Revenue
License revenue————
Operating expenses
Research and development
General and administrative
Restructuring costs—
Total operating expenses
% of revenue————
Loss from operations
% of revenue————
Other income (loss)
Interest income, net
Loss on foreign currency transactions
Research and development incentive award—
Gain on fair value adjustments
Total other income
Loss before income taxes
Income tax benefit
Net loss
% of revenue————
Net loss per share - basic
Net loss per share - diluted—